Phase 1 Driving Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults

Driving performanceCannabis, Drug Effects

Food and Drug Administration (FDA)48 enrolled2 locationsNCT07176208

Recruiting

Phase 1

The Effects of Cannabidiol on the Driving Performance of Healthy Adults by Dose and Sex

Driving performanceCannabidiol Effects

West Virginia University300 enrolled1 locationNCT06686914

Completed

Phase 1

The effect of Ketamine in combination with Dexmedetomidine or Fentanyl on measures of cognition, sedation and behaviour in healthy adults

Drugged DrivingAcute careNeurocognition

Monash Medical Centre41 enrolled1 locationACTRN12617000787381